Mayo Clinic researchers in hereditary conditions (medical genetics), nervous system conditions (neurology) and other areas study causes, diagnostic tests and potential treatments for metachromatic leukodystrophy and other conditions.
Researchers study enzyme replacement therapy, gene therapy and other potential treatments for metachromatic leukodystrophy.
See a list of publications by Mayo Clinic authors on metachromatic leukodystrophy on PubMed, a service by the National Library of Medicine.
Feb. 13, 2014
- NINDS metachromatic leukodystrophy information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/metachromatic_leukodystrophy/metachromatic_leukodystrophy.htm. Accessed Aug. 14, 2013.
- Cruse RP. Metachromatic leukodystrophy. http://www.uptodate.com/home. Accessed Aug. 14, 2013.
- Biffi A, et al. Metachromatic leukodystrophy: An overview of current and prospective treatments. Bone Marrow Transplantation. 2008;42:S2.
- Pagon RA, et al., eds. GeneReviews. Seattle, Wash.: University of Washington; 2006. http://www.ncbi.nlm.nih.gov/books/NBK1130/. Accessed Aug. 19, 2013.
- Neurological diagnostic tests and procedures. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/misc/diagnostic_tests.htm. Accessed Aug. 20, 2013.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. Aug. 2, 2013.